Case Analysis of 14 Children with Malignant Rhabdoid Tumor of the Kidney

References

• Yasui N , Yoshida A , Kobayashi E , et al. Successful treatment of extra-renal noncerebral rhabdoid tumors with VIDE. Pediatr Blood Cancer . 2016;63(2):352–354. doi:10.1002/pbc.25777 26469354
   PubMed Web of Science ®Google Scholar
• Tomlinson GE , Breslow NE , Dome J , et al. Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol . 2005;23:7641–7765. doi:10.1200/JCO.2004.00.8110 16234525
   PubMed Web of Science ®Google Scholar
• Mitchell C , Jones PM , Kelsey A , et al. The treatment of Wilms’ tumour: results of the United Kingdom Children’s cancer study group (UKCCSG) second Wilms’ tumour study. Br J Cancer . 2000;83:602–608. doi:10.1054/bjoc.2000.1338 10944599
   PubMed Web of Science ®Google Scholar
• Venkatramani R , Shoureshi P , Malvar J , et al. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer . 2014;61(8):1357–1361. doi:10.1002/pbc.25093 24789740
   PubMed Web of Science ®Google Scholar
• Joel E . Ultrastructure of malignant rhabdoid tumor of the kidney: a distinctive renal tumor of children. Hum Pathol . 1981.
   Web of Science ®Google Scholar
• Parham DM , Weeks DA , Beckwith JB . The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol . 1994;18(10):1010–1029. doi:10.1097/00000478-199410000-00005 8092393
   PubMed Web of Science ®Google Scholar
• Gururangan S , Bowman LC , Parham DM , et al. Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer . 1993;71:2653.8453588
   PubMed Web of Science ®Google Scholar
• Helmke L , Engler S , Mattke A , Henne-Bruns D . Extrarenal malignant rhabdoid tumors in childhood. Med Pediatr Oncol . 2001;36:317–319. doi:10.1002/1096-911X(20010201)36:2<317::AID-MPO1073>3.0.CO;2-W 11452943
   PubMedGoogle Scholar
• Kodet R , Newton WA , Sachs N , et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum Pathol . 1991;22:674–684. doi:10.1016/0046-8177(91)90289-2 1712749
   PubMed Web of Science ®Google Scholar
• Uwineza A , Gill H , Buckley P , et al. Rhabdoid tumor: the Irish experience 1986–2013. Cancer Genet . 2014;207(9):398–402. doi:10.1016/j.cancergen.2014.05.015 25085603
   PubMed Web of Science ®Google Scholar
• van den Heuvel—Eibrink MM , van Tinteren H , Rehorst H . Malignant rhabdoid tmours of the kidney(MRTKs), registered on recent SlOP protocols from 1993 to 2005:a report of the SIOP renal tumour study group. Pediatr Blood Cancer . 2011;56::733–737. doi:10.1002/pbc.22922 21370404
   PubMed Web of Science ®Google Scholar
• Wang Y , Zhang J , Wang Y , et al. Rhabdomyosarcoma in children: a clinical report. Chine J Practical Pediatrics . 2003;18(4):208–211.
   Google Scholar
• Ladenstein R , Pötschger U , Le Deley MC , et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro‐EWING 99 trial. J Clin Oncol . 2010;10:3284–3291. doi:10.1200/JCO.2009.22.9864
   Web of Science ®Google Scholar
• Beckwith JB , Palmer NF . Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer . 1978;41(5):1937–1948. doi:10.1002/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U 206343
   PubMed Web of Science ®Google Scholar
• Farmakis SG , Siegel MJ . Rhabdoid tumor: an aggressive renalmedullary tumor of childhood. J Comput Assist Tomogr . 2015;39(1):44–46. doi:10.1097/RCT.0000000000000195 25564301
   PubMed Web of Science ®Google Scholar
• Tomlinson GE , Breslow NE , Dome J , et al. Rhabdoid tumor of the kidney in the National Wilms’ Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol Official J Am Soc Clin Oncol . 2005;23(30):7641–7645.
   PubMed Web of Science ®Google Scholar
• Cai M , Tang J . Research progress of malignant rhabdomyosarcoma in children. Int J Blood Transfusion Hematol . 2016;39(2):169–173.
   Google Scholar
• Weeks DA , Beckwith JB , Mierau GW , et al. Rhabdoid tumor of kidney. A report of 1 1 1 cases from the National Wilms’Tumor Study Pathology Center. Am J Surg Patrol . 1989;13:439458.
   Web of Science ®Google Scholar
• Savla J , Chen TT , Schneider NR , et al. Mutations of the hSNF5/INll gene in renal rhabdoid tumors with second primary brain tumors. J Natl Cancer Inst . 2000;92:648–650. doi:10.1093/jnci/92.8.648 10772683
   PubMedGoogle Scholar
• Zhang N , He LJ . Clinicopathological features of malignant rhabdomyosarcoma in children. Chine J Pediatric Hematol Oncol . 2018;1(3):113–117.
   Google Scholar
• Hasegawa T , Yamamoto S , Yokoyama R , et al. Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk. Cancer . 2002;95(4):843–851. doi:10.1002/cncr.10728 12209729
   PubMed Web of Science ®Google Scholar
• Kohashi K , Oda Y . Oncogenic roles of sMARcBlINll and its deficienttumors. cancer Sci . 2017;108(4):547–552. doi:10.1111/cas.13173 28109176
   PubMed Web of Science ®Google Scholar
• Ramalingam P . Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathol Official J Br Division Int Acad Pathol . 2017;70:359–366.
   Google Scholar
• Bahrami A , Lee S , Caradine KD , et al. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor. Cancer Genet . 2014;207(9):437–440. doi:10.1016/j.cancergen.2014.08.002 25312828
   PubMed Web of Science ®Google Scholar
• Siegle JM , et al. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun . 2014;5:4511. doi:10.1038/ncomms5511 25077433
   PubMed Web of Science ®Google Scholar
• Justilien V , et al. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. Cancer Cell . 2014;25:139–151. doi:10.1016/j.ccr.2014.01.008 24525231
   PubMed Web of Science ®Google Scholar
• Schröck A , Bode M , Göke FJM , et al. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma. Carcinogenesis. 2014;35(7):1636–1642. doi:10.1093/carcin/bgu094 24743512
   PubMed Web of Science ®Google Scholar
• Geller JI , Roth JJ , Biegel JA . Biology and treatment of rthabdoid tumor. Crit Rev Oncog . 2015;20(3–4):199–216. doi:10.1615/CritRevOncog.2015013566 26349416
   PubMedGoogle Scholar
• Kerl K , Holsten T , Fruhwald MC . Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy. Pediatr Hematol Oncol . 2013;30(7):587–604. doi:10.3109/08880018.2013.791737 23848359
   PubMed Web of Science ®Google Scholar
• Hong CR , Kang HJ , Ju HY , et al. Extra-Cranial Malignant Rhabdoid Tumor in Children:A Single Institute Experience. Cancer ResTreat . 2015;47(4):889–896.
   Web of Science ®Google Scholar
• Furtwangler R , Kager L , Melchior P , et al. High-dosetreatment for malignant rhabdoid tumor of the kidney:No evidence for improved survival-The Gesellschaftfür P diatrische Onkologie und H matologie (GPOH) experience. Pediatr Blood Cancer . 2018;65(1):e26746. doi:10.1002/pbc.26746
   Web of Science ®Google Scholar
• Panandiker ASP , Merchant TE , Beltran C , et al. Sequencing of Local Therapy Affects the Pattern of Treatment Failure and Survival in Children With Atypical Teratoid Rhabdoid Tumors of the Central Nervous System. Int J Radiat Oncol Biol Phys . 2012;82(5):1756–1763. doi:10.1016/j.ijrobp.2011.02.059 21601374
   PubMed Web of Science ®Google Scholar
• Gounder MM , Stacchiotti S , Patrick S , et al. Phase 2 multicenter study of the EZH2 inhibitor tazemetostat in adults with INI1 negative epithelioid sarcoma (NCT02601950). J Clin Oncol . 2017;35(15_suppl):11058. doi:10.1200/JCO.2017.35.15_suppl.11058
   Web of Science ®Google Scholar